268 related articles for article (PubMed ID: 36281152)
21. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
[TBL] [Abstract][Full Text] [Related]
22. XIST as a valuable biomarker for prognosis and clinical parameters in diverse tumors: a comprehensive meta- and bioinformatics analysis.
Zhang MJ; Yan Z; Qin J; Luo TH; Yang B
Neoplasma; 2022 Sep; 69(5):1217-1227. PubMed ID: 35900315
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and prognostic value of lncRNA TPT1-AS1 in cancer: A systematic review study and meta-analysis.
Rastad H; Mozafary Bazargany MH; Samimisedeh P; Farahani M; Hashemnejad M; Moghadam S; Khodaparast Z; Shams R; Seifi-Alan M
Pathol Res Pract; 2023 May; 245():154403. PubMed ID: 37004278
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma.
Zhong LK; Zhou J; He X; He BF; Zhou XW; Zhu JL; Liu J; Qiu YH
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8008-8016. PubMed ID: 32767327
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma.
Liao C; Wang A; Ma Y; Liu H
Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of long noncoding RNA TTN-AS1 in various malignancies.
Lin G; Liu X; Cong C; Xu L
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1876. PubMed ID: 37528740
[TBL] [Abstract][Full Text] [Related]
27. The clinical prognostic value of lncRNA LINC00473 in cancer patients: A meta-analysis.
He Y; Chen Z; He J
Medicine (Baltimore); 2022 Dec; 101(52):e32465. PubMed ID: 36596056
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China.
Liu RH; Wang MY; Chen LY; Yin ZJ; Ji QK; Wang YY; Jin BZ
Oncotarget; 2018 Jan; 9(8):8100-8110. PubMed ID: 29487718
[TBL] [Abstract][Full Text] [Related]
29. Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis.
Cheng Z; Jiang S; Tao R; Ge H; Qin J
Bioengineered; 2022 Feb; 13(2):2114-2129. PubMed ID: 35034547
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNA FOXP4-AS1 Predicts Unfavourable Prognosis and Regulates Proliferation and Invasion in Hepatocellular Carcinoma.
Liang J; Wang D; Qiu G; Zhu X; Liu J; Li H; Guo P
Biomed Res Int; 2021; 2021():8850656. PubMed ID: 33604387
[TBL] [Abstract][Full Text] [Related]
32. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
Tian S; Liu J; Kong S; Peng L
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
[TBL] [Abstract][Full Text] [Related]
33. A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis.
Chen W; Qian W; Nie J; Dai M
Clin Exp Med; 2023 Feb; 23(1):65-78. PubMed ID: 35103883
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
35. FOXP4-AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer.
Hua T; Tian YJ; Wang RM; Zhao CF; Kong YH; Tian RQ; Wang W; Ma LX
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33870423
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2.
Ye J; Fu Y; Wang Z; Yu J
Cell Biol Toxicol; 2022 Dec; 38(6):1047-1062. PubMed ID: 34545456
[TBL] [Abstract][Full Text] [Related]
37. The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis.
Yang Q; Wang J; Zhong P; Mou T; Hua H; Liu P; Xie F
Cancer Cell Int; 2020; 20():72. PubMed ID: 32165862
[TBL] [Abstract][Full Text] [Related]
38. The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.
Zuo XL; Cai J; Chen ZQ; Zhang Y; Liang LH; Wang JF; Wang JG; Wu J; Mao JD
Clin Chim Acta; 2018 Oct; 485():14-20. PubMed ID: 29906419
[TBL] [Abstract][Full Text] [Related]
39. Participation of Long Noncoding RNA
Liu L; Zhao J; Guo H; Jia J; Shi L; Ma J; Zhang Z
Cancer Biother Radiopharm; 2024 Mar; ():. PubMed ID: 38512300
[No Abstract] [Full Text] [Related]
40. Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review.
Zhang F; Chen X; Xi K; Qiu Z; Wang Y; Gui Y; Hou Y; Chen K; Zhang X
Onco Targets Ther; 2018; 11():7827-7840. PubMed ID: 30464530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
